Letter Sequence Approval |
|---|
|
Initiation
- Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request, Request
- Acceptance
|
MONTHYEARML24218A2802024-08-0202 August 2024 Framatome, Inc., Request for Review and Approval of ANP-10357P, Revision 0, Txs Compact Platform Topical Report Project stage: Request ML24233A2632024-08-26026 August 2024 Summary of July 23, 2024, Pre-Submittal Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Instrumentation and Control Safety Systems TXS-Compact Topical Report Project stage: Meeting ML24256A0272024-10-0707 October 2024 The U.S. Nuclear Regulatory Commission Staff’S Acceptance for the Review of Framatome’S Topical Report, ANP-10357P, Revision 0, Txs Compact Platform Topical Report Project stage: Acceptance Review ML24352A1502025-03-13013 March 2025 March 31 - April 4, 2025, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10357P, Revision 0, Txs Compact Platform Topical Report (EPID L-2024-TOP-0029) (Audit Plan) Non-proprietary Project stage: Other ML24352A1422025-03-13013 March 2025 March 31 - April 4, 2025, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10357P, Revision 0, Txs Compact Platform Topical Report (EPID L-2024-TOP-0029) (Letter) Project stage: Other ML25188A1472025-06-30030 June 2025 Framatome, Inc. - Response to Request for Additional Documents to Be Docketed for the Review of ANP-10357P, Revision 0, Txs Compact Platform Topical Report (TR) Project stage: Request ML25154A6522025-06-30030 June 2025 Report Regarding March 31 - April 4, 2025, Regulatory Audit for Framatome Inc. ANP-10357P, Revision 0, Txs Compact Platform Topical Report (EPID L-2024-TOP-0029) - Letter Project stage: Other ML25154A6592025-06-30030 June 2025 Report Regarding March 31 - April 4, 2025, Regulatory Audit for Framatome Inc. ANP-10357P, Revision 0, Txs Compact Platform Topical Report (EPID L-2024-TOP-0029) - Non Proprietary Project stage: Other ML25203A3432025-07-22022 July 2025 Framatome, Inc., Affidavit for Philip A. Opsal Regarding 38-9394823-000, Txs Compact Quality Management Plan Project stage: Request ML25203A3402025-07-22022 July 2025 Framatome, Inc., Response to Request for Additional Documents to Be Docketed for the Review of ANP-10357P, Revision 0, Txs Compact Platform Topical Report (TR) Project stage: Request ML25203A3472025-07-22022 July 2025 Framatome, Inc., Report of QA Audit, Audit No. 730-1 Project stage: Request ML25203A3452025-07-22022 July 2025 Framatome, Inc., Affidavit for Philip A. Opsal Regarding Report of QA Audit, Audit No. 730-1 Project stage: Request ML25203A3482025-07-22022 July 2025 Framatome, Inc., Affidavit for Philip A. Opsal Regarding 38-9394824-000 Entitled, Txs Quality Assurance Plan: Txs Compact as Fpga Project stage: Request ML25226A2352025-08-14014 August 2025 Framatome, Inc., Affidavit Project stage: Request ML25226A2342025-08-14014 August 2025 Framatome, Inc., Response to Request for Additional Documents to Be Docketed for the Review of ANP-10357P Revision 0, Txs Compact Platform Topical Report (TR) Project stage: Request ML25262A1962025-11-25025 November 2025 Summary of September 19, 2025, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report, ANP-10357P, Revision 0, Txs Compact Platform Project stage: Meeting L-2025-195, Instrumentation and Control Safety Systems - NRC Review of Framatome Txs Compact Topical Report2025-12-0101 December 2025 Instrumentation and Control Safety Systems - NRC Review of Framatome Txs Compact Topical Report Project stage: Request ML25337A0952025-12-0303 December 2025 Withholding Determination Regarding Responses to Request for Additional Information (RAI)-10688 for Framatome ANP-10357P, Revision 0, Txs Compact Platform Topical Report (Form 897) Project stage: RAI ML25337A0962025-12-0404 December 2025 Withholding Determination Regarding Responses to Request for Additional Information (RAI)-10688 for Framatome ANP-10357P, Revision 0, Txs Compact Platform Topical Report (Transmittal) Project stage: RAI ML25337A4092025-12-0909 December 2025 Withholding Determination Regarding Responses to Request for Additional Information (RAI)-10636, 10637, 10638 for Framatome ANP-10357P, Revision 0, Txs Compact Platform Topical Report - NRC Form 897 Project stage: RAI ML25344A0212025-12-16016 December 2025 January 5-9, 2026, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10357P, Revision 0, Txs Compact Platform Topical Report Regarding Quality Assurance (EPID L-2024-TOP-0029) (Letter) Project stage: Other ML25344A0292025-12-16016 December 2025 January 5-9, 2026, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10357P, Revision 0, Txs Compact Platform Topical Report Regarding Quality Assurance (EPID L-2024-TOP-0029) (Non-Proprietary) Project stage: Other ML26007A0722026-01-14014 January 2026 Request for Withholding Proprietary Information from Public Disclosure - Framatome Response to Request for Additional Documents to Be Docketed for the Review of ANP-10357P, Revision 0, Txs Compact Topical Report Project stage: Approval ML26007A2412026-01-15015 January 2026 Request for Withholding Proprietary Information from Public Disclosure - Framatome Response to Request for Additional Documents to Be Docketed for the Review of ANP-10357P, Revision 0, Txs Compact Topical Report Project stage: Approval ML26020A2702026-01-16016 January 2026 Framatome, Inc. - Revised Response to Request for Additional Information 10688 - ANP-10357P, Revision 0, Txs Compact Platform Project stage: Response to RAI ML26023A0252026-01-21021 January 2026 Enclosure 4: Affidavit Project stage: Request ML26023A0212026-01-21021 January 2026 Framatome, Inc., Response to Request for Additional Documents to Support the Review of ANP-10357P, Revision 0, Txs Compact Platform Topical Report Project stage: Request ML26027A2712026-02-0303 February 2026 Request for Withholding Proprietary Information from Public Disclosure – Framatome Response to Request for Additional Documents to Support the Review of Anp 10357p, Revision 0, Txs Compact Topical Report Project stage: Approval ML26014A0912026-02-0404 February 2026 The U.S. Nuclear Regulatory Commission Staffs Revised Schedule for Review of Framatomes ANP-10357P, Revision 0, Txs Compact Platform Topical Report Project stage: Approval 2025-03-13
[Table View] |
Text
February 3, 2026 Ms. Gayle Elliott, Director Licensing and Regulatory Affairs Framatome, Inc.
3315 Old Forest Road Lynchburg, VA 24501
SUBJECT:
REQUEST FOR WITHHOLDING PROPRIETARY INFORMATION FROM PUBLIC DISCLOSURE - FRAMATOME RESPONSE TO REQUEST FOR ADDITIONAL DOCUMENTS TO SUPPORT THE REVIEW OF ANP-10357P, REVISION 0, TXS COMPACT TOPICAL REPORT (EPID L-2024-TOP-0029)
Dear Ms. Elliott:
By letter dated January 21, 2026, Framatome Inc. (Framatome) submitted an affidavit (Agencywide Documents Access and Management System (ADAMS) Accession No. ML26023A025) executed on January 20, 2026, by Nathan Hottle, to the U.S. Nuclear Regulatory Commission (NRC) requesting that the information contained in the following document be withheld from public disclosure pursuant to Title 10 of the Code of Federal Regulations (10 CFR), Section 2.390, Public inspections, exemptions, requests for withholding:
D02-ARV-01-233-823, Rev. A (38-9403159-000), TXS Compact - Documentation of Environmental (EMC, Climatic, Seismic) Type Testing (Proprietary) 51-9389344-000, TXS Compact Gap Analysis (Proprietary)
TA-B-25-006119-V2 (38-9403160-000), Tests to demonstrate behavior over time -
TXS Compact (Proprietary)
This submittal can be found in ADAMS Package Accession No. ML26023A020. All documents listed above are considered proprietary by Framatome; therefore, a non-proprietary version was not submitted.
The affidavit stated that the submitted information should be considered exempt from mandatory public disclosure for the following reasons:
a) Use of the information by a competitor would permit the competitor to significantly reduce its expenditures, in time or resources, to design, produce, or market a similar product or service.
b) The information includes test data or analytical techniques concerning a process, methodology, or component, the application of which results in a competitive advantage for Framatome.
c) The information is vital to a competitive advantage held by Framatome, would be helpful to competitors to Framatome, and would likely cause substantial harm to the competitive position of Framatome.
The NRC staff has reviewed the affidavit and the material in accordance with the requirements of 10 CFR 2.390 and based on the statements in the affidavit, it has determined that the submitted information sought to be withheld contains proprietary commercial information and should be withheld from public disclosure.
Therefore, the submitted information marked as proprietary will be withheld from public disclosure pursuant to 10 CFR 2.390(b)(5) and Section 103(b) of the Atomic Energy Act of 1954, as amended.
If the basis for withholding this information from public inspection should change in the future such that the information could then be made available for public inspection, Framatome should promptly notify the NRC. Framatome also should understand that the NRC may have cause to review this determination in the future if, for example, the scope of a Freedom of Information Act request includes Framatome information. In all review situations, the NRC will follow applicable laws, regulations, and policies in conducting its review, including the NRCs policies on notifying the owner of information in advance of any public disclosure.
If you have any questions regarding this matter, please contact me at 301-415-6695 or via email at Ngola.Otto@nrc.gov Sincerely,
/RA/
Ngola Otto, Project Manager Licensing Projects Branch Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation Docket No. 99902041
ML26027A271
- via eConcurrence NRR-084 OFFICE NRR/DORL/LLPB/PM NRR/DORL/LLPB/LA NRR/DEX/EICB/BC (A)
NRR/DORL/LLPB/PM NAME NOtto DHarrison SDarbali NOtto DATE 1/27/2026 2/2/2026 2/3/2026 2/3/2026